ArticleBlood2020

Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.

S A Srour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.